How Should We Treat HAP/VAP Caused by Carbapenemase-Producing Enterobacteriaceae?

被引：10

作者：

Bassetti, Matteo ^{[1
,2
]}

Peghin, Maddalena ^{[1
,2
]}

Carnelutti, Alessia ^{[1
,2
]}

Righi, Elda ^{[1
,2
]}

机构：

[1] Univ Udine, Dept Med, Infect Dis Clin, Udine, Italy

[2] Santa Maria Misericordia Hosp, Udine, Italy

来源：

SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE | 2017年 / 38卷 / 03期

关键词：

hospital-acquired pneumonia; ventilator-acquired pneumonia; carbapenemase-producing Enterobacteriaceae; antibiotic therapy; multidrug-resistant gram negative; VENTILATOR-ASSOCIATED PNEUMONIA; CRITICALLY-ILL PATIENTS; INTENSIVE-CARE-UNIT; RESPIRATORY-TRACT INFECTIONS; HOSPITAL-ACQUIRED PNEUMONIA; KLEBSIELLA-PNEUMONIAE; RISK-FACTORS; RESISTANT ENTEROBACTERIACEAE; COLISTIN METHANESULFONATE; RETROSPECTIVE ANALYSIS;

D O I：

10.1055/s-0037-1602656

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

Hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP) represent a common problem in hospital setting worldwide. Infections caused by carbapenem-resistant Enterobacteriaceae (CRE) are an emergent problem due to the lack of therapeutic options available, leading to significant increases in morbidity and mortality. CRE have frequently been reported both in HAP/VAP, but limited data regarding the optimal treatment strategy in this setting are available. This review focuses on the current epidemiology of CRE, with a specific focus on HAP/VAP. Moreover, we will suggest a possible strategy for the empiric and targeted treatment of HAP and VAP in which the involvement of CRE is suspected or is confirmed.

引用

页码：301 / 310

页数：10

共 50 条

[41] Emergence of carbapenemase-producing Enterobacteriaceae in France, 2004 to 2011
Vaux, S.
Carbonne, A.
Thiolet, J. M.
Jarlier, V.
Coignard, B.
EUROSURVEILLANCE, 2011, 16 (22): : 11 - 17
[42] Clonal spread of carbapenemase-producing Enterobacteriaceae in a region, China
Changfu Yin
Weiwei Yang
Yuanpeng Lv
Peng Zhao
Jiansheng Wang
BMC Microbiology, 22
[43] Carbapenemase-producing Enterobacteriaceae in Finland: the first years (200811)
Osterblad, Monica
Kirveskari, Juha
Hakanen, Antti J.
Tissari, Paivi
Vaara, Martti
Jalava, Jari
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2012, 67 (12) : 2860 - 2864
[44] Prospective evaluation of a screening algorithm for carbapenemase-producing Enterobacteriaceae
Choquet, Morgane
Guiheneuf, Raphael
Castelain, Sandrine
Pluquet, Emilie
Decroix, Veronique
JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2019, 33 (03)
[45] Recent advances in the laboratory detection of carbapenemase-producing Enterobacteriaceae
Matsumura, Yasufumi
Pitout, Johann D.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2016, 16 (07) : 783 - 794
[46] Hazard Ratios and Hazardous Carbapenemase-Producing Enterobacteriaceae Reply
Dautzenberg, Mirjam J. D.
Bonten, Marc J. M.
Derde, Lennie P. G.
CRITICAL CARE MEDICINE, 2015, 43 (11) : E537 - E538
[47] Combination therapy for bloodstream infections with carbapenemase-producing Enterobacteriaceae
Salzberger, Bernd
Faetkenheuer, Gerd
LANCET INFECTIOUS DISEASES, 2017, 17 (10): : 1020 - 1020
[48] Occurrence and Characterization of Carbapenemase-Producing Enterobacteriaceae in a Tunisian Hospital
Ben Helal, Rania
Dziri, Raoudha
Chedly, Meriem
Klibi, Naouel
Barguellil, Farouk
El Asli, Mohamed Selim
Ben Moussa, Mohamed
MICROBIAL DRUG RESISTANCE, 2018, 24 (09) : 1361 - 1367
[49] Importance of the Respiratory Tract in Carbapenemase-Producing Enterobacteriaceae Spread
Perez Martinez, Olaia
Garcia Rodriguez, Raquel
Pereira Rodriguez, Ma Jose
Varela Camino, Angela
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2020, 41 : S284 - S285
[50] Occurrence of carbapenemase-producing Enterobacteriaceae in Togo, West Africa
Dossim, Sika
Bonnin, Remy A.
Salou, Mounerou
Tanga, Kpatcha
Godonou, Virginie
Dagnra, Anoumou Yaotse
David, Mireille Prince
Naas, Thierry
Dortet, Laurent
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2019, 53 (04) : 530 - 532

← 1 2 3 4 5 →